Literature DB >> 1615763

Risk of fractures in patients with pernicious anemia.

J B Goerss1, C H Kim, E J Atkinson, R Eastell, W M O'Fallon, L J Melton.   

Abstract

In a series of postmenopausal women previously studied by our group, pernicious anemia was associated with reduced bone mineral density of the spine and with vertebral fractures. To determine whether osteoporotic fractures represent an important clinical problem for such patients, we conducted a population-based retrospective cohort study of all Rochester, Minnesota residents newly diagnosed with pernicious anemia from 1950 through 1979. These 131 individuals were followed through the inpatient and outpatient records of all medical care providers in the community for 1550 person-years. In comparison with fracture rates from the general community, patients with pernicious anemia had a 1.9-fold increase in proximal femur fractures, a 1.8-fold increase in vertebral fractures, and a 2.9-fold increase in distal forearm fractures (all p less than 0.05). Increases in the risk of proximal humerus and pelvis fractures were not statistically significant. Clinicians should be aware that pernicious anemia is associated with an increased risk of osteoporotic fractures, but the mechanism is unknown.

Entities:  

Mesh:

Year:  1992        PMID: 1615763     DOI: 10.1002/jbmr.5650070514

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  20 in total

Review 1.  The risks of PPI therapy.

Authors:  Paul Moayyedi; Grigorios I Leontiadis
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-14       Impact factor: 46.802

Review 2.  B vitamins, homocysteine, and bone disease: epidemiology and pathophysiology.

Authors:  Robert R McLean; Marian T Hannan
Journal:  Curr Osteoporos Rep       Date:  2007-09       Impact factor: 5.096

3.  Hip fracture risk in patients with a diagnosis of pernicious anemia.

Authors:  Nathan A Merriman; Mary E Putt; David C Metz; Yu-Xiao Yang
Journal:  Gastroenterology       Date:  2009-12-21       Impact factor: 22.682

Review 4.  Proton pump inhibitors and fracture risk: true effect or residual confounding?

Authors:  Michael Bodmer; Christian Meier; Marius E Kraenzlin; Christoph R Meier
Journal:  Drug Saf       Date:  2010-10-01       Impact factor: 5.606

Review 5.  Adverse effects of long-term proton pump inhibitor therapy.

Authors:  Edward Sheen; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2011-03-02       Impact factor: 3.199

6.  Low bone mineral density and bone mineral content are associated with low cobalamin status in adolescents.

Authors:  Rosalie A M Dhonukshe-Rutten; Marijke van Dusseldorp; Jörn Schneede; Lisette C P G M de Groot; Wija A van Staveren
Journal:  Eur J Nutr       Date:  2004-08-30       Impact factor: 5.614

7.  Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study.

Authors:  B Abrahamsen; K H Rubin; P A Eiken; R Eastell
Journal:  Osteoporos Int       Date:  2012-10-16       Impact factor: 4.507

8.  Bone density and hemoglobin levels in older persons: results from the InCHIANTI study.

Authors:  Matteo Cesari; Marco Pahor; Fulvio Lauretani; Brenda W H J Penninx; Benedetta Bartali; Roberto Russo; Antonio Cherubini; Richard Woodman; Stefania Bandinelli; Jack M Guralnik; Luigi Ferrucci
Journal:  Osteoporos Int       Date:  2004-09-28       Impact factor: 4.507

9.  Chronic gastritis and bone mineral density in women.

Authors:  Adriana M Kakehasi; Carolinne B Rodrigues; Ariane V Carvalho; Alfredo J A Barbosa
Journal:  Dig Dis Sci       Date:  2008-08-07       Impact factor: 3.199

10.  Proton pump inhibitors and risk of bone fractures.

Authors:  Grigorios I Leontiadis; Paul Moayyedi
Journal:  Curr Treat Options Gastroenterol       Date:  2014-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.